Breathe Well Live Well
Condition: Cystic Fibrosis
Interventions: Drug: N91115; Drug: Placebo
Sponsors: Nivalis Therapeutics, Inc.; Medidata Solutions
Not yet recruiting – verified October 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Placebo ELLIPTA inhaler; Other: Questionnaire
Sponsor: GlaxoSmithKline
Not yet recruiting – verified October 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Nebulized Magnesium Sulfate; Drug: Nebulized isotonic saline; Drug: Nebulized Salbutamol; Drug: Ipratropium bromide; Drug: Methylprednisolone or Prednisolone
Sponsor: Hospital General Naval de Alta Especialidad
Recruiting – verified October 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: dupilumab SAR231893/REGN668; Drug: placebo; Drug: fluticasone propionate and salmeterol; Drug: budesonide and formoterol; Drug: mometasone furoate and formoterol
Sponsors: Sanofi; Regeneron Pharmaceuticals
Not yet recruiting – verified October 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: beclomethasone; Drug: fluticasone
Sponsor: University of Virginia
Not yet recruiting – verified October 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Asthma; Obesity
Interventions: Other: Standard Control; Behavioral: a provider administered, tailored discussion guide
Sponsor: Henry Ford Health System
Recruiting – verified October 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Asthma (Part 1); COPD (Part 2)
Interventions: Drug: Dose 1, AZD8871 50 ?g (Part 1); Drug: Dose 2, AZD8871 100 ?g (Part 1); Drug: Dose 3, AZD8871 300 ?g (Part 1); Drug: Dose 4, AZD8871 600 µg (Part 1); Drug: Dose 5, AZD8871 1200 µg (Part 1); Drug: Dose 6, AZD8871 1800 ?g (Part 1); Drug: Placebo, AZD8871 placebo (Part 1); Drug: Treatment A, AZD8871 dose A (Part 2); Drug: Treatment B, AZD8871 dose B (Part 2); Drug: Treatment C, Indacaterol 150 ?g (Part 2); Drug: Treatment D, Tiotropium 18 ?g (Part 2)
Sponsor: AstraZeneca
Not yet recruiting – verified October 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Vitamin D3; Drug: Vitamin D3
Sponsor: Hospital General Naval de Alta Especialidad
Not yet recruiting – verified October 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Hay Fever
Interventions: Biological: Placebo solution; Biological: gpASIT+TM
Sponsor: BioTech Tools S.A.
Not yet recruiting – verified September 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Device: T-Piece Nebulizer; Device: Breath-Enhanced Nebulizer; Drug: Albuterol; Procedure: Pre-Treatment Spirometry Measurement; Procedure: Post-Treatment Spirometry Measurement
Sponsors: Seton Healthcare Family; University of Texas
Not yet recruiting – verified September 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days